Inventor
JAGGI MANU
IN26 patents
⚠️ This page may combine multiple inventors who share the name “JAGGI MANU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DABUR RES FOUNDATION
16 patentsUS6632832B1Oct 14, 2003
Anti-cancer activity of carvedilol and its isomers
DABUR RES FOUNDATION25 citations92
US6403816B1Jun 11, 2002
Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
DABUR RES FOUNDATION33 citations90
US6395771B1May 28, 2002
Paclitaxel derivatives for the treatment of cancer
DABUR RES FOUNDATION21 citations89
US6670345B1Dec 30, 2003
Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid
DABUR RES FOUNDATION27 citations88
US6228850B1May 8, 2001
Antiangiogenic activity of betulinic acid and its derivatives
DABUR RES FOUNDATION20 citations82
US6596692B1Jul 22, 2003
Substance P analogs for the treatment of cancer
DABUR RES FOUNDATION8 citations73
US6828304B1Dec 7, 2004
Peptides for treatment of cancer
DABUR RES FOUNDATION10 citations72
US6316414B1Nov 13, 2001
Somatostatin analogs for the treatment of cancer
DABUR RES FOUNDATION13 citations72
US6613793B2Sep 2, 2003
Anticancer activity of imino acid conjugates or methylglyoxal
DABUR RES FOUNDATION11 citations70
US6214814B1Apr 10, 2001
Use of betulinic acid derivatives for inhibiting cancer growth
DABUR RES FOUNDATION8 citations65
US7173006B2Feb 6, 2007
Drug comprising synthetic peptide analogs for the treatment of cancer
DABUR RES FOUNDATION3 citations61
US7060678B2Jun 13, 2006
Peptides comprising furanoid sugar amino acids for the treatment of cancer
DABUR RES FOUNDATION3 citations58
US6989371B1Jan 24, 2006
Bombesin analogs for treatment of cancer
DABUR RES FOUNDATION1 citations51
US6949513B2Sep 27, 2005
Polypeptides of covalently linked synthetic bioactive peptide analog(s) for treatment of cancer
DABUR RES FOUNDATION0 citations51
US7179937B2Feb 20, 2007
Cyclopentenone derivatives for cancer therapy
DABUR RES FOUNDATION0 citations30
US6949557B2Sep 27, 2005
Hydroanthracene based compounds as anticancer agents
DABUR RES FOUNDATION0 citations28
NAT INST IMMUNOLOGY
3 patentsUS5744363AApr 28, 1998
Method for establishing a tumor-cell line by preparing single-cell suspension of tumor cells from tumor biopsies
NAT INST IMMUNOLOGY18 citations92
US6156725ADec 5, 2000
Drug for the treatment of cancer
NAT INST IMMUNOLOGY16 citations83
US6492330B1Dec 10, 2002
Antiangiogenic drugs
NAT INST IMMUNOLOGY10 citations71